Broadcasting News

Yoo Jae-suk’s Health Raises Concerns… High Fever Leads to Cancellations “At Every Opportunity”

"Temporary high fever due to cold-like symptoms"

Gim Ga Yeong
2026-09-22 13:03:08
[Edaily Starin Gim Ga Yeong Reporter] TV personality Yoo Jae-suk canceled the recording of “Whenever I Get a Chance” due to health reasons.
Yoo Jae-suk
On the 22nd, a representative from Antenna, Yoo Jae-suk’s agency, explained to E-Daily, “Mr. Yoo Jae-suk was forced to cancel the recording due to a temporary high fever caused by a cold and body aches,” adding, “He is currently focusing on his recovery, and we have asked for the understanding of those involved and are coordinating a reschedule.”
Earlier that day, MyDaily reported that Yoo Jae-suk, while preparing to film SBS’s “Whenever I Get a Chance” near Jongno, Seoul, informed the production crew of his health condition just before filming was set to begin, leading to the cancellation of the shoot.
“Whenever I Get the Chance” is a variety show that delivers luck during the brief moments of downtime encountered in everyday life. Yoo Jae-suk and Yoo Yeon-seok serve as the hosts.

Economy

Corporation

IT·Science

Economy

KBI METAL CO., LTD., Which Has Expanded Its Wire and Cable Business, Posts Record Cumulative Operating Profit… but Slows Down in the Third Quarter

KBI METAL CO., LTD.’s Eumseong Plant Office Building. (Photo courtesy of KBI Group) KBI METAL CO., LTD. posted its highest-ever cumulative operating profit for the first three quarters of this year,…
2026-11-13 22:11:12

Corporation

[Exclusive] Lotte Group to Announce Regular Personnel Shuffle on the 16th… All Eyes on Whether President Shin Yu-yeol Will Be Promoted

Lotte Group will hold board meetings for its affiliates as early as the 16th to carry out its regular executive reshuffle. Following last year’s replacement of 20 chief executive officers (CEOs), all …
2026-11-13 22:52:44

IT·Science

HANDOK Inc.: Partner Company’s Rare Hypoglycemia Treatment Set to Draw Attention This Year… Results of External Collaboration Put to the Test

Resolute announced to the U.S. Securities and Exchange Commission (SEC) on the 14th (local time) that it had completed patient enrollment for the Phase 3 clinical trial of “Ersodetug.” (Source: U.S. S…
2026-11-13 15:42:02